Purple Biotech Ltd ADR [NASDAQ: PPBT] stock went on an upward path that rose over 150.37% on Monday, amounting to a one-week price increase of more than 283.56%.
Over the last 12 months, PPBT stock dropped by -59.62%. The one-year Purple Biotech Ltd ADR stock forecast points to a potential upside of 74.55. The average equity rating for PPBT stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $15.46 million, with 1.84 million shares outstanding and 1.82 million shares in the current float. Compared to the average trading volume of 49.34K shares, PPBT stock reached a trading volume of 47781245 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Purple Biotech Ltd ADR [PPBT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PPBT shares is $33.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PPBT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Purple Biotech Ltd ADR is set at 1.18 The Price to Book ratio for the last quarter was 0.50, with the Price to Cash per share for the same quarter was set at 3.42.
PPBT Stock Performance Analysis:
Purple Biotech Ltd ADR [PPBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 283.56. With this latest performance, PPBT shares gained by 161.68% in over the last four-week period, additionally sinking by -43.24% over the last 6 months – not to mention a drop of -59.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PPBT stock in for the last two-week period is set at 83.33, with the RSI for the last a single of trading hit 90.41, and the three-weeks RSI is set at 75.83 for Purple Biotech Ltd ADR [PPBT]. The present Moving Average for the last 50 days of trading for this stock 3.94, while it was recorded at 4.08 for the last single week of trading, and 8.99 for the last 200 days.
Insight into Purple Biotech Ltd ADR Fundamentals:
Purple Biotech Ltd ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.27 and a Current Ratio set at 1.27.
Purple Biotech Ltd ADR [PPBT] Institutonal Ownership Details
The top three institutional holders of PPBT stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.36 million shares, which is approximately 5.2352%. KINGSWOOD WEALTH ADVISORS, LLC, holding 0.21 million shares of the stock with an approximate value of $$84680.0 in PPBT stocks shares; and KINGSWOOD WEALTH ADVISORS, LLC, currently with $$82621.0 in PPBT stock with ownership which is approximately 0.7826%.
